Sharechat Logo

Pacific Edge shares gain 6.5% on first commercial deal in Singapore

Thursday 1st February 2018

Text too small?

Pacific Edge shares rose 6.5 percent after the cancer diagnostics firm signed its first commercial deal to supply its suite of Cxbladder tests in Singapore. 

The stock increased 2.5 cents to 41 cents after the Dunedin-based company said it reached a commercial agreement with a unit of Raffles Medical Group to use the bladder cancer tests in Singapore, the company said in a statement. Under the deal, the Raffles unit will coordinate specimen collection, shipping and reporting of Cxbladder tests for the medical firm's patients in the Asian city. 

"We are delighted to work with the prestigious Raffles Medical Group in Singapore and whilst this is a relatively small commercial proposition for Pacific Edge, it offers a significant stepping stone into the Raffles Medical Group across South East Asia," Pacific Edge chief executive David Darling said. "The region remains an exciting proposition for Pacific Edge with approximately 9,500 urologists and an estimated 1.8 million potential tests."

Pacific Edge raised $21.3 million in a discounted rights issue last year, which it said left it flush enough to fund the operation until it starts breaking even in 2019.

The company's international ambitions have rested largely on breaking into the US market, although that's taken longer than expected, and started eyeing Singapore as a gateway to South East Asia in 2015. 

Raffles operates in 13 cities across Singapore, China, Japan, Vietnam and Cambodia, and is in the only fully integrated private healthcare operation in Singapore. 

(BusinessDesk)

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MARKET CLOSE: NZ shares rise as optimism over US-China trade deal lingers; Fletcher gains
NZD under pressure against Aussie as investors cheered by easing of trade jitters
PFI properties’ valuation rises 5.5% to $1.32 billion
Broader definition of workplace harm in new govt health & safety strategy
MBIE officials grilled on terms of Westland Milk loan
Trade Me suitor Hellman & Friedman drops out
Hydrogen not a short-term option for Huntly - Genesis
Kiwibank says customers have a dwindling need of physical branches
Buying off the plans driving down KiwiBuild cost to govt: HYEFU
Fiscal policy to slow growth over next five years, despite surpluses

IRG See IRG research reports